theMednet - What additional evaluation or surveillance would you recommend for a patient with a persistently elevated PSA > 50 but repeatedly negative biopsies, MRI, and PSMA PET?

Community
Company
News
Contact Us
Sign in

Topics: Genitourinary Cancers • Medical Oncology • Urology • Urologic Oncology

What additional evaluation or surveillance would you recommend for a patient with a persistently elevated PSA > 50 but repeatedly negative biopsies, MRI, and PSMA PET?

How often would you repeat biopsy if at all, or just follow PSA and re-image if significant rise?

Related Questions

Is it appropriate to offer definitive trimodality therapy, as an equivalent option to neoadjuvant chemotherapy followed by radical cystectomy, in patients with muscle-invasive bladder cancer regardless of fitness or platinum eligibility?

In a patient with very high risk prostate cancer opting for prostatectomy, when, if ever, do you recommend neoadjuvant ADT?

Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?

What is your approach to surveillance in patients with no evidence of disease after treatment of oligometastatic renal cell carcinoma?

What is the optimal management of malignant mesothelioma of the tunica vaginalis testis (MMTVT) found incidentally after hydrocelectomy?

How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?

Which patients do you consider to be good candidates for salvage local treatment after radiation therapy?

Is there a clinical benefit for a repeat TURBT to ensure complete resection of the bladder tumor prior to neoadjuvant chemotherapy and radical cystectomy?

Is there evidence that prostatectomy improves overall survival in local recurrence of prostate cancer post-definitive radiation?

How would you treat a metastatic pure urethral adenocarinoma?